A mid-stage biotech developing a novel therapeutic candidate was approaching a BLA submission with a fragmented regulatory history spanning multiple years and contributors. Internal knowledge gaps and disorganized documentation threatened to create significant roadblocks at a critical milestone. The company turned to Bracken to restore order and build the infrastructure needed for submission readiness.
What Made This Difficult
Three interconnected problems had compounded over time, each making the others worse.
Limited visibility into prior FDA communications and submission content due to staff turnover and poor documentation practices
Significant time lost to locating, reconciling, or recreating critical documents for ongoing submissions
Institutional knowledge not captured in any centralized system — regulatory history lived in individual memory, not accessible files
How Bracken Solved It
Bracken conducted a forensic reconstruction of the company's regulatory history while simultaneously building the infrastructure to prevent the same problems from recurring.
Forensic Regulatory Reconstruction
Bracken conducted a comprehensive review of prior FDA interactions — pulling together fragmented communications, submissions, and agency feedback to build a complete and navigable regulatory history that the team could confidently rely on.
Document Management Strategy
Bracken developed a centralized, customized document tracking system covering FDA communications, cover letters, submission modules, and decision rationale — organized as a living content log aligned with the company's internal workflows.
Institutional Knowledge Transfer
Bracken facilitated structured onboarding for new regulatory team members — turning fragmented institutional knowledge into actionable checklists, documented processes, and contextual reference materials.
Measurable Outcomes
Regulatory documentation is not just a compliance requirement — it's a strategic asset. By restoring continuity and embedding best practices, Bracken turned a fragmented regulatory story into a well-documented, forward-looking submission strategy — and gave the team the infrastructure to maintain that standard as they scaled toward commercialization.
Common Questions About This Topic
Regulatory history reconstruction is the process of systematically recovering and organizing prior FDA interactions — including submissions, agency feedback, and correspondence — when that history has become fragmented due to staff turnover, poor documentation practices, or organizational change. It is typically needed before BLA or NDA submissions when the team cannot confidently account for all prior commitments and outstanding issues.
When key regulatory team members leave, they take institutional knowledge with them. If prior FDA feedback, submission rationale, or commitment tracking was not centrally documented, the incoming team may unknowingly repeat past mistakes, miss outstanding commitments, or contradict earlier agency positions — all of which can delay or jeopardize submissions.
An effective system should organize FDA communications, submission modules, cover letters, meeting minutes, and the rationale for key development decisions — with version control and clear ownership. It should function as a living log that is updated continuously, not assembled retroactively before each submission.
Experienced regulatory consultants bring both process knowledge and FDA interaction expertise that most internal teams lack — particularly at mid-stage companies. Bracken's approach focuses on identifying and closing gaps proactively, so the team isn't discovering issues during submission review.
